According to Barron the former GSK culture had stifled innovation by focusing too much on safe bets rather than game-changing drugs that could lead to major commercial success. Barron said ...

Now, speaking to him as the first vaccines are deployed in the UK, he highlights the importance of GSK’s employees and culture to the future of the company post-COVID. Despite becoming UK GM at ...

GSK shares have been weighed down by concern ... “It's important to foster a culture of creativity and transformative ...

GSK has historically been strong in vaccines ... and driven a very strong performance culture,” he said. Other investors think she has a “tough gig”. One top-20 shareholder said it ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw in activist ...

GSK’s research and development foundation, ‘Science x Technology x Culture’, is driving the innovation (science) x investment (technology) x patient centricity (culture) behind our approach ...

Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have gone elsewhere without tax incentives approved by local officials last year.

Partnership is integral to GSK. Bringing people together is the best way to innovate and deliver products that transform the standard of care and improve lives. Over half of GSK’s clinical ...

“Our culture of diversity ... Meanwhile, in its annual report published on Thursday, British drugmaker GSK (NYSE:GSK) said it would no longer set "aspirational targets"—in reference to ...

During Walmsley’s near eight-year tenure, GSK shares have delivered a total annualized return of about 3%, compared with more than 7% for peers, according to data compiled by Bloomberg. GSK has ...